Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Identification of Bartonella Species Directly in Clinical Specimens by PCR-Restriction Fragment Length Polymorphism Analysis of a 16S rRNA Gene Fragment

Ghassan M. Matar, Jane E. Koehler, Georgia Malcolm, Mary Ann Lambert-Fair, Jordan Tappero, Suzan B. Hunter, Bala Swaminathan
Ghassan M. Matar
Department of Microbiology and Immunology, American University of Beirut, Beirut, Lebanon;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane E. Koehler
Department of Medicine, Division of Infectious Diseases, University of California at San Francisco, San Francisco, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgia Malcolm
Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Ann Lambert-Fair
Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan Tappero
Department of Medicine, Division of Infectious Diseases, University of California at San Francisco, San Francisco, California; and
Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzan B. Hunter
Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bala Swaminathan
Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.37.12.4045-4047.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

It is now established that two species of Bartonella, namely, Bartonella henselae and B. quintana, cause bacillary angiomatosis in human immunodeficiency virus-infected patients. In addition, B. henselae causes cat scratch disease and B. quintana, B. henselae, andB. elizabethae can cause bacteremia and endocarditis in immunocompetent persons. We have developed a PCR-restriction fragment length polymorphism-based assay for direct detection and identification to species level of Bartonella in clinical specimens. This is accomplished by PCR amplification of Bartonella DNA using primers derived from conserved regions of the gene carrying the 16S ribosomal DNA, followed by restriction analysis usingDdeI and MseI restriction endonucleases. We amplified a Bartonella genus-specific 296-bp fragment from 25 clinical samples obtained from 25 different individuals. Restriction analysis of amplicons showed that identical patterns were seen from digestion of B. henselae and B. quintanaamplicons with DdeI, whereas a different unique pattern was seen by using the same enzyme with B. vinsonii and B. elizabethae. With MseI digestion, B. henselae and B. vinsonii gave nearly identical patterns while B. quintana and B. elizabethaegave a different pattern. By combining the restriction analysis data generated with MseI and DdeI, unique “signature” restriction patterns characteristic for each species were obtained. These patterns were useful in identifying theBartonella species associated with each tissue specimen.

Twelve species ofBartonella have been identified. Four, Bartonella henselae, B. quintana, B. elizabethae, andB. bacilliformis, are recognized as human pathogens, and one, B. clarridgeiae, has been implicated as a human pathogen by serology (8, 13, 15). B. bacilliformis, the first organism in the genus to be identified, causes bartonellosis (3). Recently, B. henselaewas detected by PCR (1) and isolated from the lymph nodes of patients with cat scratch disease (CSD) (6), as well as from the blood of pet cats (11, 12), providing strong evidence for B. henselae as the causative agent of CSD. Both B. henselae and B. quintana cause bacteremia and bacillary angiomatosis in both immunocompromised and immunocompetent persons (10, 11, 18). B. quintana is also the etiologic agent of trench fever (20, 21), and both B. quintana and B. elizabethae can cause endocarditis (4, 7, 16, 20).

The implication of these Bartonella species in a variety of human diseases and the difficulty in isolating them from clinical specimens underscore an urgent need for better detection and identification methods. Birtles identified Bartonellaspecies by PCR-restriction fragment length polymorphism (RFLP) analysis (2). We describe the development of a PCR-RFLP assay for the identification of Bartonella to the species level and demonstrate the application of this method directly to clinical diagnostic specimens.

MATERIALS AND METHODS

Bartonella DNA fragments were amplified from 25 tissue specimens, including fresh or paraffin-embedded clinical specimens (lymph node or lymph node aspirates, skin, subcutaneous nodules, or other tissues), obtained from patients participating in epidemiologic studies of CSD and bacillary angiomatosis (19). Amplifications of control tissues were also run in parallel. Control isolates were B. henselae B91-002000,B. vinsonii B92-010225, B. elizabethaeB92-002005, and B. quintana ATCC VR-358.

Bartonella species were grown on Trypticase soy agar with 5% sheep blood or on chocolate agar plates for 4 to 7 days at 37°C. A few colonies (8 to 10) were harvested in 1 ml of 0.1 M phosphate-buffered saline, pH 7.0. Template DNA was prepared from suspended cells or from fresh or paraffin-embedded clinical specimens by the method described by Heller et al. (9). Positive and negative controls were processed for DNA preparation and PCR amplification along with the clinical specimens. The negative control was a section of fresh or paraffin-embedded skin free ofBartonella infection. The positive control was eitherBartonella organisms or paraffin slices that had been artificially contaminated with Bartonella organisms.

Ten microliters of bacterial or tissue lysates was used to amplify the 16S ribosomal DNA (rDNA) fragment by the method of Relman et al. (14). PCR amplification was carried out in 100-μl reaction mixtures consisting of 10 μl of DNA and 90 μl of the amplification mix, which contained the following components: 20 pmol each of p12B and p24E primers, 0.5 mM MgCl2, 200 μM each deoxynucleoside triphosphate, 10 μl of Gene Amp PCR buffer (Perkin-Elmer, Norwalk, Conn.), and 2.5 U of Taq DNA polymerase (Perkin-Elmer).

The PCR amplification was performed in a PC-100 Thermal controller (MJ Research, Watertown, Mass.) for 35 cycles. Each cycle consisted of 120 s at 94°C, 60 s at 60°C, and 90 s at 72°C, and a final extension of 10 min at 72°C was done. The amplified products were detected by electrophoresis on a 1% agarose gel (14 by 14 cm) in 1× Tris-borate-EDTA buffer at 100 V for 60 min. Gels were stained with ethidium bromide and photographed. PCR controls included a known positive DNA extract and a reagent blank.

For digestion of PCR-amplified DNA from cultures and clinical specimens, 10 to 15 μl of PCR-amplified DNA was restricted with 10 U of DdeI and MseI in a total volume of 15 to 20 μl, respectively, according to the manufacturer's specifications (New England Biolabs, Inc., Beverly, Mass.). The restriction fragments were separated by electrophoresis on agarose gels (4% NuSieve agarose [3:1] [FMC Bioproducts, Rockland, Maine] at 60 V for 2 h. Gels were photographed and fragment sizes were determined with interpolation by using the BioImage system whole-band software analysis (Millipore Corp., Ann Arbor, Mich.).

For clinical specimens with PCR-amplified DNA revealing more than one band, the 296-bp DNA in the agarose gel was detected with ethidium bromide, excised, and placed in a 1.5-ml microcentrifuge tube. The agarose slice was washed once with 500 μl of Tris-EDTA buffer and twice with enzyme buffer. The buffer was discarded, and the agarose plug was cut into small pieces. Ten units of the restriction enzymes (DdeI and MseI) was added in a 100-μl solution (10× buffer [10 μl], bovine serum albumin [2.5 μl], and deionized water to a volume of 100 μl). DNA was precipitated from the supernatant with 3 M sodium acetate and 2.5 volumes of 95% cold ethanol. The pellet was washed once in cold 70% ethanol, dried in a vacuum dessicator, and dissolved in 20 μl of water. Fragments were detected by electrophoresis on 4% NuSieve agarose gels and were analyzed as described previously.

RESULTS

Figure 1 shows the 296-bp fragment as well as the various RFLP patterns derived from digestion of amplicons of the four species with DdeI and MseI, and Table 1 lists the observed and predicted sizes of the fragments from the digested amplicons. B. henselae and B. quintana gave nearly identical patterns with DdeI, whereas B. vinsonii and B. elizabethae gave a different and unique pattern. WithMseI, B. henselae and B. vinsonii had nearly identical patterns, and B. quintana and B. elizabethae had patterns different from those of B. henselae and B. vinsonii but nearly identical to each other. Composite types generated from restriction analysis usingDdeI and MseI were unique for each species (Table1).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

PCR-RFLP of B. henselae, B. vinsonii, B. elizabethae, and B. quintana. Lane 1, 50-bp ladder; lanes 2 to 4, B. henselae B91-002000; lanes 5 to 7, B. vinsonii B92-010225; lanes 8 to 10,B. elizabethae B92-002005; lanes 11 to 13, B. quintana ATCC VR-358; lane 14, 50-bp ladder. PCR products were uncut (lanes 2, 5, 8, and 11) or cut with DdeI (lanes 3, 6, 9, and 12) or MseI (lanes 4, 7, 10, and 13).

View this table:
  • View inline
  • View popup
Table 1.

Identification of Bartonella species by PCR-RFLP analysis of a 16S rDNA fragment

Table 2 shows the distribution ofBartonella species among 25 clinical specimens. Twenty-one of 26 (81%) of the isolates gave the restriction pattern for B. henselae, 4 (15.38%) gave that for B. quintana, and 1 (4%) gave that for B. elizabethae. The RFLP patterns ofB. henselae and B. quintana obtained from clinical specimens are shown in Fig. 2. All 21 B. henselae amplified PCR products have the same composite restriction pattern with DdeI and MseI. This pattern is identical to that found for the B. henselaetype strain (B91-002000). All four B. quintana amplified PCR products have the same composite restriction pattern, which is identical to that of the B. quintana type strain (ATCC VR-358). It should be noted that minor differences in fragment lengths among isolates within the same species may be encountered (5). The sizes of digested DNA fragments are shown in Table1.

View this table:
  • View inline
  • View popup
Table 2.

Distribution of Bartonella species among clinical diagnostic specimens evaluated

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

PCR-RFLP of B. quintana and B. henselae from clinical specimens. Lane 1, 50-bp ladder, lanes 2 to 4, B. quintana H93-176; lanes 5 to 7, B. henselaeB92-007003; lane 8, blank; lanes 9 to 11, B. quintanaB93-007356; lane 12, 50-bp ladder. PCR products were left uncut (lanes 2, 5, and 9) or were cut with DdeI (lanes 3, 6, and 10) orMseI (lanes 4, 7, and 11).

DISCUSSION

We were able to differentiate among the differentBartonella species implicated in human disease by extending the 16S rDNA-based detection method for Bartonella species by using restriction analysis of the 296-bp amplicons. This was achieved by generating species-specific composite patterns based on digestion of 16S rDNA amplicons with DdeI andMseI restriction enzymes. The RFLP method was applied to amplicons from clinical specimens, allowing direct species identification for these specimens. The predicted and observed fragment lengths for all four species matched each other. Predicted fragments 28 for B. vinsonii and B. elizabethae cut withDdeI were not observed because they were small and were not visualized on gels.

Our method was shown to be more advantageous than a previously described method (1) because only one set of primers was used in this study, followed by restriction analysis, allowing for direct identification in a variety of clinical specimens of theBartonella species implicated in human disease (Table 2). Although the method described by Anderson et al. (1) allows for the detection of B. quintana and B. henselaein lymph nodes and lymph node aspirates, it requires multiple steps and the use of radioactive probes.

Our PCR-RFLP-based assay may offer the advantage of early diagnosis of suspected Bartonella species infections and can be used to differentiate among three species causing human disease in North America. This rapid and specific test is an alternative to culture that provides more-timely information to clinicians, who can then direct antibiotic therapy and suggest prevention strategies to their patients based on species-specific test results (11).

ACKNOWLEDGMENTS

This work was initiated in 1993 while G.M.M. was a Visiting Associate at the Centers for Disease Control and Prevention (CDC).

This study is supported in part by NIH R29 AI36075 and the California Universitywide AIDS Research Program (to J.E.K.).

FOOTNOTES

    • Received 18 June 1999.
    • Returned for modification 3 August 1999.
    • Accepted 24 August 1999.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Anderson B.,
    2. Sims K.,
    3. Regnery R.,
    4. Robinson L.,
    5. Schmidt M. J.,
    6. Goral S.,
    7. Hager C.,
    8. Edwards K.
    Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR.J. Clin. Microbiol.321994942948
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Birtles J. B.
    Differentiation of Bartonella species using restriction endonuclease analysis of PCR-amplified 16S rRNA genes.FEMS Microbiol. Lett.1291995261266
    OpenUrlPubMed
  3. 3.↵
    1. Brenner D. J.,
    2. O'Connor S. P.,
    3. Winkler H.,
    4. Steigart A. G.
    Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from the order Rickettsialles.Int. J. Syst. Bacteriol.431993777786
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Daly J. S.,
    2. Worthington M. G.,
    3. Brenner D. J.,
    4. Moss C. W.,
    5. Hollis D. G.,
    6. Weyant R. S.,
    7. Steigerwalt A. G.,
    8. Weaver R. E.,
    9. Daneshvar M. I.,
    10. O'Connor S. P.
    Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis.J. Clin. Microbiol.311993872881
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Dauga C.,
    2. Miras I.,
    3. Grimont P. A. D.
    Identification of Bartonella henselae and B. quintana 16S rDNA sequences by branch-genus and species-specific amplification.J. Med. Microbiol.451996192199
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Dolan M. J.,
    2. Wong M. T.,
    3. Regnery R. L.,
    4. Jorgensen J. H.,
    5. Garcia M.,
    6. Peter J.,
    7. Drehner D.
    Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease.Ann. Intern. Med.1181993331336
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Drancourt M.,
    2. Mainardi J. L.,
    3. Brouqui P.,
    4. Vandenesch F.,
    5. Carta A.,
    6. Lehnert F.,
    7. Etienne J.,
    8. Goldstein F.,
    9. Acar J.,
    10. Raoult D.
    Bartonella (Rochalimaea) quintana endocarditis in three homeless men.N. Engl. J. Med.3321995419423
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Ellis B. A.,
    2. Regenry R. L.,
    3. Beati L.,
    4. Bacellar F.,
    5. Rood M.,
    6. Glass G. G.,
    7. Marston E.,
    8. Ksiazek T. G.,
    9. Jones D.,
    10. Childs J. E.
    Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J. Infect. Dis. 180 1999 220 224
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Heller M. J.,
    2. Burgart L. J.,
    3. TenEyck C. J.,
    4. Anderson M. E.,
    5. Greiner T. C.,
    6. Robinson R. A.
    An efficient method for the extraction of DNA from formalin-fixed, paraffin-embedded tissue by sonication.BioTechniques111991372377
    OpenUrlPubMedWeb of Science
  10. 10.↵
    1. Koehler J. E.,
    2. Quinn F. D.,
    3. Berger T. G.,
    4. Leboit P. E.,
    5. Tappero J. W.
    Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis.N. Engl. J. Med.327199216251631
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Koehler J. E.,
    2. Sanchez M. A.,
    3. Carrido C. S.,
    4. Whitfeld M. J.,
    5. Berger T. G.,
    6. Rodriguez-Barradas M. C.,
    7. LeBoit P. E.,
    8. Tappero J. W.
    Molecular epidemiology of Bartonella infections in patients with bacillary angiomatosis-peliosis.N. Engl. J. Med.337199718761883
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Koehler J. E.,
    2. Glasser C. A.,
    3. Tappero J. W.
    Rochalimaea henselae infection: a new zoonosis with the domestic cat as reservoir.JAMA2711994531535
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Kordick D. L.,
    2. Hilyard E. J.,
    3. Hadfield T. L.,
    4. Wilson K. H.,
    5. Steigerwalt A. G.,
    6. Brenner D. J.,
    7. Breitschwerdt E. B.
    Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease).J. Clin. Microbiol.35199718131818
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Relman D. A.,
    2. Loutit J. S.,
    3. Schmidt T. M.,
    4. Falkow S.,
    5. Tompkins L. S.
    The agent of bacillary angiomatosis; an approach to the identification of uncultured pathogens.N. Engl. J. Med.323199015731580
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Slater L.,
    2. Welch D. F.,
    3. Hensel D.,
    4. Coody D. W.
    A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia.N. Engl. J. Med.323199015871593
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Spach D. H.,
    2. Kanter A. S.,
    3. Daniels N. A.,
    4. Nowowiejski D. J.,
    5. Larson A. M.,
    6. Schmidt R. A.,
    7. Swaminathan B.,
    8. Brenner D. J.
    Bartonella (Rochalimaea) species as a cause of apparent “culture negative” endocarditis.Clin. Infect. Dis.20199510441047
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.
    1. Spach D. H.,
    2. Kanter A. S.,
    3. Dougherty M. J.,
    4. Larson A. M.,
    5. Coyle M. B.,
    6. Brenner D. J.,
    7. Swaminathan B.,
    8. Matar G. M.,
    9. Welch D. F.,
    10. Root R. K.,
    11. Stamm W. E.
    Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism.N. Engl. J. Med.3321995424428
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Tappero J. W.,
    2. Koehler J. E.,
    3. Berger T. G.,
    4. et al.
    Bacillary angiomatosis and bacillary splenitis in immunocompetent adults.Ann. Intern. Med.1181993363365
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Tappero J. W.,
    2. Mohle-Boetani J. C.,
    3. Koehler J. E.,
    4. et al.
    The epidemiology of bacillary angiomatosis and bacillary peliosis.JAMA2691993770775
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Vinson J. W.,
    2. Fuller H. S.
    Studies on trench fever. 1. Propagation of Rickettsia-like organisms from a patient's blood.Pathol. Microbiol.241961S152S166
    OpenUrlCrossRef
  21. 21.↵
    1. Vinson J. W.,
    2. Varela G.,
    3. Molina-Pasquel C.
    Trench fever. 3. Introduction of clinical disease in volunteers inoculated with Rickettsia quintana propagated on blood agar.Am. J. Trop. Med. Hyg.181969713722
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Identification of Bartonella Species Directly in Clinical Specimens by PCR-Restriction Fragment Length Polymorphism Analysis of a 16S rRNA Gene Fragment
Ghassan M. Matar, Jane E. Koehler, Georgia Malcolm, Mary Ann Lambert-Fair, Jordan Tappero, Suzan B. Hunter, Bala Swaminathan
Journal of Clinical Microbiology Dec 1999, 37 (12) 4045-4047; DOI: 10.1128/JCM.37.12.4045-4047.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of Bartonella Species Directly in Clinical Specimens by PCR-Restriction Fragment Length Polymorphism Analysis of a 16S rRNA Gene Fragment
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Identification of Bartonella Species Directly in Clinical Specimens by PCR-Restriction Fragment Length Polymorphism Analysis of a 16S rRNA Gene Fragment
Ghassan M. Matar, Jane E. Koehler, Georgia Malcolm, Mary Ann Lambert-Fair, Jordan Tappero, Suzan B. Hunter, Bala Swaminathan
Journal of Clinical Microbiology Dec 1999, 37 (12) 4045-4047; DOI: 10.1128/JCM.37.12.4045-4047.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bartonella
Bartonella Infections
polymerase chain reaction
Polymorphism, Restriction Fragment Length

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X